Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib. J Clin Oncol 2008 Jul 10;26(20):3460-2
Date
07/10/2008Pubmed ID
18612164DOI
10.1200/JCO.2008.16.9391Scopus ID
2-s2.0-49149087664 (requires institutional sign-in at Scopus site) 37 CitationsAuthor List
Braiteh F, Kurzrock R, Johnson FMAuthor
Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antineoplastic Combined Chemotherapy ProtocolsBiopsy, Fine-Needle
Brain Neoplasms
Carcinoma, Bronchogenic
ErbB Receptors
Erlotinib Hydrochloride
Eyelashes
Female
Follow-Up Studies
Humans
Hypertrichosis
Lung Neoplasms
Magnetic Resonance Imaging
Middle Aged
Neoplasm Invasiveness
Neoplasm Staging
Quinazolines
Risk Assessment
